Verastem, Inc.
Nasdaq VSTM · Needham, MA
Works in GI & liver · Metabolic & endocrine · Oncology · Renal & urogenital · Respiratory · Women's health
Verastem, Inc. is a clinical trial sponsor based in Needham, MA, listed as Nasdaq VSTM. It has 10 active clinical trials with 1,762 planned participants, across 6 therapeutic areas. Since 2021 it has completed 3 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq VSTM
Fundraising
Pipeline · 10 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
1 approved drug application with a product on the market.
Questions about Verastem, Inc
Verastem, Inc is lead sponsor of 10 active clinical trials on ClinicalTrials.gov, with 1,762 planned participants, in GI & liver, Metabolic & endocrine, Oncology, Renal & urogenital and other areas. Since 2021 it has completed 3 trials and stopped 1 early.
Verastem, Inc is based in Needham, MA and is listed as Nasdaq VSTM. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Verastem, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
Approve Suite is not affiliated with Verastem, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.